You reviewed ....
for this content
out of 5
Event : Acute Cardiovascular Care 2019
Topic : Other
Acute Coronary Syndromes: Biomarkers, Pharmacotherapy and Prevention - Poster discussant - 12:45 - 13:45.
Acute Cardiovascular Care 2019
A novel high-sensitivity cardiac troponin i assay for early diagnosis of acute myocardial infarction
miR-1 and miR-126 concentrations in patients with acute myocardial infarction ?treated invasively.
Without rhyme or reason...are we abusing of troponin testing?
Prognostic value of high sensitivity troponin T second peak occurrence after ST elevation myocardial infarction
Early p2y12 inhibitors escalation in st segment elevation myocardial infarction: prevalence, impact on platelet production and function, and long-term prognosis
Early versus delayed treatment with ticagrelor on residual thrombus after percutaneous coronary intervention in patients presenting with non-ST-elevation acute coronary syndrome
Clinical parameters associated with ST segment resolution 60 minutes after fibrinolytic in STEMI patients
Polymorphism rs776746 in the gene of cyp3a5 is able to us for predicting of clinical efficiency of bisoprolol in patients with acute coronary syndromec
Efficacy and safety of association of abciximab with prasugrel or ticagrelor in patients undergoing percutaneous intervention.
Prognosis of arterial thromboembolic complications in patients with extrasystolic arrhythmia
Degrees in the coronary flow impairment related to therapy and diastolic dysfunction in patients with non-obstructive coronary artery disease
The Utilisation of predischarge checklist for effective patient communication in acute coronary syndrome patients.
Which canc prevent cardiac remodelling in high risk patients, control of hypertension or control of diabetes?
Association of the vasoactive therapy with impairment in coronary flow and persistence of angina in patients with non-obstructive coronary disease and slow coronary flow
Improvement of lipid profile post cardiac rehabilitation in patients with previous ACS according to the patient's level of risk
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease